[1] Snell N,Newbold P.The clinicalutility of biomarkers in asthma and COPD[J].Curr Opin Pharmaco,2008,8(3):222. [2] Amer MS,W ahba HM ,Ashmawi SS,et al.Proinflammatory cytokines in Egyptian elderly with chronic obstructive pulmonary disease[J].Lung India,2010,27(4):225-229. [3] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-15. [4] Agusti A,Faner R.Systemic inflammation and comorbidities in chronic obstructive pulmonary disease[J].Proc Am Thorae Soc,2012,9(2):43-46. [5] Rovina N,Dima E,Gerassimou C,et al.Interleukin-18 in induced sputum:association with lung function in chronic obstructive pulmonary disease[J].Respir Med,2009,103(7):1056-1062. [6] 赵修斌,曾亚,肖云武. 慢性阻塞性肺疾病患者血中炎性因子变化与呼吸功能的相关性研究[J].实用预防医学,2007,8(1):86-88. [7] 赵亚丽,杨振汉,向华国,等. 白介素-6与慢性阻塞性肺疾病患者营养不良关系的研究[J]. 实用预防医学,2010,17(1):93,183. [8] Safir H,Mortaz E,Janse WT,et al.IL-8 production bymacrophages is synergistically enhanced when cigarette smoke is combined with TNF-alpha[J].Biochem Pharmacol,2010,79(5):698-705. [9] 龙仕居,陈忠仁.慢性阻塞性肺疾病患者急性加重期与缓解期痰液及血清IL-6、IL-8、TNF-α表达水平的差异及其临床意义[J].重庆医学,2012,41(19):1970-1972. [10] Sethi S.Molecular diagnosis of respiratory tract infection in acute exacerbations of chronic obstructive pulmonary disease[J].Clin Infect Dis,2011,52(Suppl 4):290-295. [11] Yf L,Yu Y,Lu ZF.Serum levels of II 13 and TNF-α lpha in children with Mycoplasma pneumoniae pneumonia [J].Zhongguo Dang Dai Er Ke Za Zhi,2010,12(4):275-277. [12] Mathew JL, Patwari AK,Gupta P,et al.Acute respiratory infection and pneumonia in India:a systematic review of literature for advocacy and action:UNICEF-PHF1 series on newborn and child health,India[J].Indian Pediatr,2011,48(3):191-218. [13] Kersul AL,Iglesias A,Rlos A,et al.Molecular mechanisms of inflammarion during exacerbations of chronic obstructive pulmonary disease[J].Arch Bronconeumol,2011,47(4):176-183.
2017, Vol. 24 
